Gland Pharma Schedules May Investor Meetings

Gland Pharma intimated scheduled analyst and institutional investor meetings for May 2026 pursuant to SEBI LODR regulations.
Meetings include one-on-one sessions with Carnelian Asset Management and Ashmore Investment Management.
The company will also participate in group and one-on-one meetings at the 360 ONE Capital Investor Conference.
Schedule is subject to change due to exigencies from investors, analysts, or the company.